Category: Biotechnology

Marc Beer Is Helping Women Overcome Pelvic Floor Disorders With New Technology

A common health problem that a number of women suffer from each year is urinary incontinence. This common health problems occurs for a number of reasons. Some women may experience this condition due to childbirth while others might have developed an infection and suffered long term effects from it. No matter the reason, Marc Beer is working to make it easier for women and men to overcome this problem. Learn more: https://www.cnbc.com/video/2013/01/23/aegerion-ceo-on-promise-of-biopharma.html

Marc Beer is responsible for creating sensor technologies to work on helping others overcome this condition. Through the use of sensors and technology, the goal is to help patients discover new treatment options for their overall urinary and pelvic conditions. Coming up with innovative solutions is what he does best.

 

Renovia has been created to come up with new and exciting ways to bring commercial products to life in the first line of the diagnosis and treatment options to improve the overall health conditions of patients. The overall quality of life that a woman might experience can be devastating without the proper help. It is the hope of Renovia to help women who suffer from the pelvic floor disorders to be able to regain their self image once more by cutting back the number of concerns they are faced with monthly due to the pelvic floor disorders.

 

The hope of Renovia is to monitor in real life movement what a patient is experiencing. The technology that has been created will allow precise visualization for the patient suffering from the pelvic floor disorders. It will offer insight into the pelvic muscle training as well as taking notes for progress reports over time. Marc Beer was hoping that with his help, there would be more cost effective methods to be used to help patients suffering from pelvic disorders over long periods of time.

 

The start of Renovia has led women down a path that they might have otherwise not known about if the discovering of technology and diagnostic devices had not yet been discovered by individuals looking to help patients overcome health effects caused from Pelvic floor disorders. With the start of Renovia, there has been in increase in the money used to come up with new and exciting ways to overcome these health problems. With the funding of 42.3 million dollars behind them, Marc Beer is sure to come up with top of the line solutions for patients suffering from this condition or diagnosis.

Follow Marc Beer on LinkedIn

 

Marc Beer and the Science of Healthcare

Marc Beer obtained his BS from the University of Miami (Ohio). He is currently the CEO and co-founder of the company Renovia, a start-up that’s primary focus is on women’s health and pelvic floor disorders. Beer has over 25 years of experience in commercialization and development in many industries including pharmaceuticals, devices, biotechnology, and diagnostics.

 

Prior to his position at Renovia, Marc Beer has held many other lucrative positions including the Vice President of Global Marketing for the company Genzyme. Later, he worked for Abbott Laboratories, performing well in various sales and marketing roles. Beer was also the founding CEO of ViaCell in April of 2000. While at ViaCell, Beer sat on the board of directors for the company Erytech Pharma. He has also been a member of the Mass Life Science Board of the Commonwealth of Massachusetts. Beer has been a founding chairman at Good Start Genetics, Inc. and Minerva Neurosciences, Inc.

In April, Renovia had obtained their first FDA approval of the new product, Leva. Renovia has been researching and developing therapeutic and diagnostic solutions for pelvic floor disorders for women, such as urinary incontinence, which affects over 250 million women worldwide.

 

More recently, Renovia has received over $42 million in funds to further their research. They plan to use the funding to develop four more products, which will include an updated version of their first product, Leva. While $32 million of the funding came from a Series B round, $10 came from venture debt. The Longwood Fund, a firm that invests in healthcare companies and has been investing in Renovia since the beginning, jumped in the Series B round along with Perceptive Advisors, a New York-based firm, and Ascension Ventures, a Missouri-based firm. Learn more: https://renoviainc.com/

 

Marc Beer has stated that he is excited to begin this project with their new investors. Renovia’s passion to help patients by using innovative technologies and the digital healthcare platform will greatly influence how much they are able to help their customers who treat patients. The funding and research will enable Renovia to develop products that will yield more knowledge about pelvic floor disorders. This information will help to lower healthcare costs for every aspect of treatment.